<p>温哥华，不列颠哥伦比亚省 --（Newsfile Corp. -2026 年 3 月 3 日）- Restart Life Sciences Corp.（CSE: HEAL）（FSE: HN30）（OTC Pink: NMLSF）（&#34;Restart Life&#34;或&#34;公司&#34;）很高兴地宣布，在成功收购 Holy Crap Foods Inc.之后，公司已与曼尼托巴大学的理查森食品技术与研究中心（RCFTR）达成合作，以支持一系列与食品相关的科学研究，这些研究将指导公司在不断扩展的功能性健康产品组合中的产品开发路线图。</p>
<p>与 RCFTR 的新合作伙伴关系代表了 Restart Life 在推动促进大脑健康、认知健康、肠脑轴支持和长期活力的功能性食品使命中的重要一步。该合作将专注于验证产品配方、优化成分功能、增强生物利用度，并确保公司品牌的长期稳定性和质量。</p>
<p>&#34;随着我们将 Holy Crap™产品整合到我们的产品组合中，并继续开发我们的 BrainQ™和 BrainBalls™品牌，确保我们的创新建立在严格的科学评估基础上至关重要，&#34;Restart Life Sciences Corp.的首席执行官 Steve Loutskou 表示。&#34;与 RCFTR 的合作使我们能够获得世界级的食品科学专业知识和设施。这一合作将帮助确保我们的产品在扩大功能性健康平台时，符合最高的有效性、一致性和质量标准。&#34;</p>
<p>理查森食品技术与研究中心的研究开发经理 Michael Janzen 博士也对这一合作表示了热情，称：_&#34;_我们期待与 Restart Life Sciences 密切合作，推动他们的功能性产品线。他们的关注点与我们的研究能力高度契合，我们很高兴能支持他们当前和未来配方背后的科学基础。&#34;</p>
<p><strong>支持 BrainQ™、BrainBalls™、Holy Crap™及未来功能性食品的开发</strong></p>
<p>Restart Life Sciences 最近推出并推进了多个消费者健康品牌，包括 BrainQ™，这是一个使用与认知支持相关的天然成分配制的功能性产品线；BrainBalls™，一种旨在促进日常大脑健康的营养丰富的零食；以及 Holy Crap™，一个以消化健康和基础营养支持而闻名的清洁标签植物性功能性食品品牌。</p>
<p>Holy Crap™的加入将公司的功能性健康平台扩展到肠道健康，这一领域与大脑表现和整体健康通过肠脑轴的联系日益紧密。</p>
<p>与曼尼托巴大学理查森食品技术与研究中心（RCFTR）的合作将帮助建立成分评估、配方性能和未来产品开发的科学框架，涵盖所有产品线，包括 BrainQ™、BrainBalls™和 Holy Crap™。</p>
<p><strong>研究范围和目标</strong></p>
<p>与 RCFTR 的研究合作旨在生成广泛的科学见解，以支持 Restart Life 功能性健康产品组合的持续发展，包括其大脑健康和消化健康产品类别。</p>
<p>该工作可能包括与成分质量、配方完整性和整体功能性能相关的探索性评估，包括在各种环境条件下的一般稳定性考虑。</p>
<p>该项目还可能评估成分在各种配方中的表现，以帮助识别可能指导未来优化工作的趋势。这可能涉及审查感官特性、营养保留和潜在降解模式，以及探索优化成分特性或增强功能益处的机会。</p>
<p>在适当的情况下，该项目可能包括对选择性活性成分的生物利用度和功能潜力的初步考虑，这些工作将通过 RCFTR 或在其他第三方专家的支持下进行。这些见解将有助于指导产品的改进、创新和公司不断扩展的功能性食品平台的长期研究方向。</p>
<p>交付成果可能包括高水平的科学观察、技术摘要和建议，以支持持续的产品开发、质量评估和科学验证工作。</p>
<p><strong>关于理查森食品技术与研究中心（RCFTR）</strong></p>
<p>理查森食品技术与研究中心是一个占地 55,000 平方英尺的现代化设施，位于曼尼托巴大学的福特加里校园。该中心致力于推动食品质量、人类营养和功能性食品的创新。它提供小规模加工、分析测试、成分评估、产品开发以及包括制粉、制片和包埋在内的专业服务。RCFTR 前身为理查森功能性食品与营养品中心，是一个支持传统和下一代食品技术的领先研究中心。</p>
<p><strong>对之前宣布的贷款融资的澄清</strong></p>
<p>根据公司于 2025 年 12 月 22 日发布的新闻稿，公司宣布已签署一项臂长贷款协议，金额为 CAD</p>
<p>$250,000</p>
<p>（&#34;贷款融资&#34;），公司希望澄清，除了贷款融资的年利率为</p>
<p>12%</p>
<p>的利息外，公司还将向贷款人发行 2,500,000 个认购权证，行使价格为</p>
<p>$0.10</p>
<p>每股，有效期为自发行之日起两年。</p>
<p>Restart Life Sciences 感谢其股东的持续支持，因为公司在推进其使命并继续执行其战略。</p>
<p><strong>关于 Restart Life Sciences Corp.</strong></p>
<p>Restart Life Sciences Corp. 是一家总部位于加拿大的生命科学公司，上市于 CSE。有关 Restart Life 的更多信息，请访问公司网站 www.restartlife.co。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含构成 “前瞻性声明” 的陈述。这些前瞻性声明涉及已知和未知的风险、不确定性以及其他可能导致 Restart Life Sciences 的实际结果、表现或成就，或行业发展与预期结果、表现或成就存在重大差异的因素。前瞻性声明是指那些不是历史事实的陈述，通常但不总是通过 “预期”、“计划”、“预计”、“相信”、“打算”、“估计”、“项目”、“潜在” 和类似表达来识别，或者表明事件或条件 “将”、“会”、“可能”、“能够” 或 “应该” 发生。</p>
<p>加拿大证券交易所及其市场监管机构（根据加拿大证券交易所的政策定义）对本声明的充分性或准确性不承担任何责任。</p>
<p><strong>代表董事会</strong></p>
<p>Steve Loutskou</p>
<p>首席执行官，Restart Life Sciences Corp.</p>
<p>电话：+1 (778) 819-0244</p>
<p>电子邮件：hello@restartlife.co</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8801/286069_1dd4f052a431db07_logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8801/286069_1dd4f052a431db07_logo.jpg"/></p>
<p>要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/286069</p>
<p><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/286069/375?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/286069/375"/></p>

ATNF

ATNFW

<p>Restart Life Sciences Corp. 宣布与曼尼托巴大学的理查森食品技术与研究中心合作，以支持与食品相关的科学研究。此次合作旨在增强其功能性健康产品组合的产品开发，包括 BrainQ™、BrainBalls™ 和 Holy Crap™ 品牌。合作将重点验证配方、优化成分并确保产品质量。此外，公司还澄清了之前宣布的 250,000 加元贷款融资的细节，其中包括利息和股票购买权证</p>

<p>Vancouver, British Columbia--(Newsfile Corp. - March 3, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) (&#34;Restart Life&#34; or the &#34;Company&#34;) is pleased to announce that, following the successful acquisition of Holy Crap Foods Inc., it has entered into a collaboration with the University of Manitoba's Richardson Centre for Food Technology and Research (RCFTR) to support a series of food-related scientific studies that will guide the Company's product development roadmap across its expanding functional wellness portfolio.</p>
<div class="lb-trans"><p>温哥华，不列颠哥伦比亚省 --（Newsfile Corp. -2026 年 3 月 3 日）- Restart Life Sciences Corp.（CSE: HEAL）（FSE: HN30）（OTC Pink: NMLSF）（&#34;Restart Life&#34;或&#34;公司&#34;）很高兴地宣布，在成功收购 Holy Crap Foods Inc.之后，公司已与曼尼托巴大学的理查森食品技术与研究中心（RCFTR）达成合作，以支持一系列与食品相关的科学研究，这些研究将指导公司在不断扩展的功能性健康产品组合中的产品开发路线图。</p>
</div><p>This new partnership with RCFTR represents a meaningful step in Restart Life's mandate to advance functional foods that promote brain health, cognitive wellness, gut-brain axis support, and long-term vitality. The collaboration will focus on validating product formulations, optimizing ingredient functionality, enhancing bioavailability, and ensuring long-term stability and quality across the Company's brands.</p>
<div class="lb-trans"><p>与 RCFTR 的新合作伙伴关系代表了 Restart Life 在推动促进大脑健康、认知健康、肠脑轴支持和长期活力的功能性食品使命中的重要一步。该合作将专注于验证产品配方、优化成分功能、增强生物利用度，并确保公司品牌的长期稳定性和质量。</p>
</div><p>&#34;As we integrate Holy Crap™ products into our portfolio and continue developing our BrainQ™ and BrainBalls™ brands, it is essential that our innovation is grounded in rigorous scientific assessment,&#34; said Steve Loutskou, CEO of Restart Life Sciences Corp. &#34;Partnering with RCFTR gives us access to world-class food science expertise and facilities. This collaboration will help ensure our products meet the highest standards of efficacy, consistency, and quality as we scale our functional wellness platform.&#34;</p>
<div class="lb-trans"><p>&#34;随着我们将 Holy Crap™产品整合到我们的产品组合中，并继续开发我们的 BrainQ™和 BrainBalls™品牌，确保我们的创新建立在严格的科学评估基础上至关重要，&#34;Restart Life Sciences Corp.的首席执行官 Steve Loutskou 表示。&#34;与 RCFTR 的合作使我们能够获得世界级的食品科学专业知识和设施。这一合作将帮助确保我们的产品在扩大功能性健康平台时，符合最高的有效性、一致性和质量标准。&#34;</p>
</div><p>Dr. Michael Janzen, Research Development Manager at the Richardson Centre for Food Technology and Research, also expressed enthusiasm for the collaboration, stating: <em>&#34;</em> We look forward to working closely with Restart Life Sciences as they advance their functional product lines. Their focus aligns strongly with our research capabilities, and we are excited to support the scientific foundation behind their current and future formulations.&#34;</p>
<div class="lb-trans"><p>理查森食品技术与研究中心的研究开发经理 Michael Janzen 博士也对这一合作表示了热情，称：_&#34;_我们期待与 Restart Life Sciences 密切合作，推动他们的功能性产品线。他们的关注点与我们的研究能力高度契合，我们很高兴能支持他们当前和未来配方背后的科学基础。&#34;</p>
</div><p><strong>Supporting the Development of BrainQ™, BrainBalls™, Holy Crap™, and Future Functional Foods</strong></p>
<div class="lb-trans"><p><strong>支持 BrainQ™、BrainBalls™、Holy Crap™及未来功能性食品的开发</strong></p>
</div><p>Restart Life Sciences has recently introduced and advanced several consumer health brands, including BrainQ™, a functional product line formulated using natural ingredients associated with cognitive support; BrainBalls™, a nutrient-dense snack designed to promote daily brain wellness; and Holy Crap™, a clean-label, plant-based functional food brand recognized for digestive health and foundational nutrition support.</p>
<div class="lb-trans"><p>Restart Life Sciences 最近推出并推进了多个消费者健康品牌，包括 BrainQ™，这是一个使用与认知支持相关的天然成分配制的功能性产品线；BrainBalls™，一种旨在促进日常大脑健康的营养丰富的零食；以及 Holy Crap™，一个以消化健康和基础营养支持而闻名的清洁标签植物性功能性食品品牌。</p>
</div><p>The addition of Holy Crap™ expands the Company's functional wellness platform beyond cognitive health into gut health, an area increasingly linked to brain performance and overall well-being through the gut-brain axis.</p>
<div class="lb-trans"><p>Holy Crap™的加入将公司的功能性健康平台扩展到肠道健康，这一领域与大脑表现和整体健康通过肠脑轴的联系日益紧密。</p>
</div><p>The partnership with the Richardson Centre for Food Technology and Research (RCFTR) at the University of Manitoba will help establish a scientific framework for ingredient evaluation, formulation performance, and future product development across all product lines, including BrainQ™, BrainBalls™, and Holy Crap™.</p>
<div class="lb-trans"><p>与曼尼托巴大学理查森食品技术与研究中心（RCFTR）的合作将帮助建立成分评估、配方性能和未来产品开发的科学框架，涵盖所有产品线，包括 BrainQ™、BrainBalls™和 Holy Crap™。</p>
</div><p><strong>Research Scope and Objectives</strong></p>
<div class="lb-trans"><p><strong>研究范围和目标</strong></p>
</div><p>The research collaboration with RCFTR is intended to generate broad scientific insights that support the ongoing development of Restart Life's functional wellness portfolio, including its brain health and digestive health product categories.</p>
<div class="lb-trans"><p>与 RCFTR 的研究合作旨在生成广泛的科学见解，以支持 Restart Life 功能性健康产品组合的持续发展，包括其大脑健康和消化健康产品类别。</p>
</div><p>The work may include exploratory evaluations related to ingredient quality, formulation integrity, and overall functional performance, including general stability considerations under a range of environmental conditions.</p>
<div class="lb-trans"><p>该工作可能包括与成分质量、配方完整性和整体功能性能相关的探索性评估，包括在各种环境条件下的一般稳定性考虑。</p>
</div><p>The program may also assess how ingredients behave within various formulations to help identify trends that could guide future optimization efforts across BrainQ™, BrainBalls™, and Holy Crap™ products. This could involve reviewing sensory characteristics, nutrient retention, and potential degradation patterns, as well as exploring opportunities to refine ingredient profiles or enhance functional benefits.</p>
<div class="lb-trans"><p>该项目还可能评估成分在各种配方中的表现，以帮助识别可能指导未来优化工作的趋势。这可能涉及审查感官特性、营养保留和潜在降解模式，以及探索优化成分特性或增强功能益处的机会。</p>
</div><p>Where appropriate, the project may include preliminary considerations of bioavailability and the functional potential of select active components, conducted either through RCFTR or with support from additional third-party specialists. These insights will help inform product refinement, innovation, and longer-term research directions across the Company's expanding functional food platform.</p>
<div class="lb-trans"><p>在适当的情况下，该项目可能包括对选择性活性成分的生物利用度和功能潜力的初步考虑，这些工作将通过 RCFTR 或在其他第三方专家的支持下进行。这些见解将有助于指导产品的改进、创新和公司不断扩展的功能性食品平台的长期研究方向。</p>
</div><p>Deliverables may include high-level scientific observations, technical summaries, and recommendations that support ongoing product development, quality assessment, and scientific validation initiatives.</p>
<div class="lb-trans"><p>交付成果可能包括高水平的科学观察、技术摘要和建议，以支持持续的产品开发、质量评估和科学验证工作。</p>
</div><p><strong>About the Richardson Centre for Food Technology and Research (RCFTR)</strong></p>
<div class="lb-trans"><p><strong>关于理查森食品技术与研究中心（RCFTR）</strong></p>
</div><p>The Richardson Centre for Food Technology and Research is a 55,000-square-foot, state-of-the-art facility located at the University of Manitoba's Fort Garry Campus. The Centre is dedicated to advancing food quality, human nutrition, and innovation in functional foods. It offers pilot-scale processing, analytical testing, ingredient evaluation, product development, and specialized services including milling, tableting, and encapsulation. Formerly known as the Richardson Centre for Functional Foods and Nutraceuticals, the RCFTR is a leading research hub supporting both traditional and next-generation food technologies.</p>
<div class="lb-trans"><p>理查森食品技术与研究中心是一个占地 55,000 平方英尺的现代化设施，位于曼尼托巴大学的福特加里校园。该中心致力于推动食品质量、人类营养和功能性食品的创新。它提供小规模加工、分析测试、成分评估、产品开发以及包括制粉、制片和包埋在内的专业服务。RCFTR 前身为理查森功能性食品与营养品中心，是一个支持传统和下一代食品技术的领先研究中心。</p>
</div><p><strong>Clarification of Previously Announced Loan Financing</strong></p>
<div class="lb-trans"><p><strong>对之前宣布的贷款融资的澄清</strong></p>
</div><p>Further to the Company's news release dated December 22, 2025, whereby the Company announced that it had entered into an arm's-length loan agreement in the principle amount of CAD</p>
<div class="lb-trans"><p>根据公司于 2025 年 12 月 22 日发布的新闻稿，公司宣布已签署一项臂长贷款协议，金额为 CAD</p>
</div><p>$250,000</p>
<div class="lb-trans"><p>$250,000</p>
</div><p>(the &#34;Loan Financing&#34;), the Company wishes to clarify that, in addition to the interest at a rate of</p>
<div class="lb-trans"><p>（&#34;贷款融资&#34;），公司希望澄清，除了贷款融资的年利率为</p>
</div><p>12%</p>
<div class="lb-trans"><p>12%</p>
</div><p>per annum payable on the Loan Financing, the Company shall also issue the lender 2,500,000 share purchase warrants, exercisable at</p>
<div class="lb-trans"><p>的利息外，公司还将向贷款人发行 2,500,000 个认购权证，行使价格为</p>
</div><p>$0.10</p>
<div class="lb-trans"><p>$0.10</p>
</div><p>per share and valid for a term of two years from issuance.</p>
<div class="lb-trans"><p>每股，有效期为自发行之日起两年。</p>
</div><p>Restart Life Sciences would like to thank its shareholders for their ongoing support as the Company advances its mission and continues to execute on its strategy.</p>
<div class="lb-trans"><p>Restart Life Sciences 感谢其股东的持续支持，因为公司在推进其使命并继续执行其战略。</p>
</div><p><strong>About Restart Life Sciences Corp.</strong></p>
<div class="lb-trans"><p><strong>关于 Restart Life Sciences Corp.</strong></p>
</div><p>Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the CSE. For more information about Restart Life, please visit the Company's website at www.restartlife.co.</p>
<div class="lb-trans"><p>Restart Life Sciences Corp. 是一家总部位于加拿大的生命科学公司，上市于 CSE。有关 Restart Life 的更多信息，请访问公司网站 www.restartlife.co。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This news release contains statements that constitute &#34;forward-looking statements.&#34; Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Restart Life Sciences' actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words &#34;expects,&#34; &#34;plans,&#34; &#34;anticipates,&#34; &#34;believes,&#34; &#34;intends,&#34; &#34;estimates,&#34; &#34;projects,&#34; &#34;potential&#34; and similar expressions, or that events or conditions &#34;will,&#34; &#34;would,&#34; &#34;may,&#34; &#34;could&#34; or &#34;should&#34; occur.</p>
<div class="lb-trans"><p>本新闻稿包含构成 “前瞻性声明” 的陈述。这些前瞻性声明涉及已知和未知的风险、不确定性以及其他可能导致 Restart Life Sciences 的实际结果、表现或成就，或行业发展与预期结果、表现或成就存在重大差异的因素。前瞻性声明是指那些不是历史事实的陈述，通常但不总是通过 “预期”、“计划”、“预计”、“相信”、“打算”、“估计”、“项目”、“潜在” 和类似表达来识别，或者表明事件或条件 “将”、“会”、“可能”、“能够” 或 “应该” 发生。</p>
</div><p>Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.</p>
<div class="lb-trans"><p>加拿大证券交易所及其市场监管机构（根据加拿大证券交易所的政策定义）对本声明的充分性或准确性不承担任何责任。</p>
</div><p><strong>On behalf of the Board of Directors</strong></p>
<div class="lb-trans"><p><strong>代表董事会</strong></p>
</div><p>Steve Loutskou</p>
<div class="lb-trans"><p>Steve Loutskou</p>
</div><p>Chief Executive Officer, Restart Life Sciences Corp.</p>
<div class="lb-trans"><p>首席执行官，Restart Life Sciences Corp.</p>
</div><p>Tel: +1 (778) 819-0244</p>
<div class="lb-trans"><p>电话：+1 (778) 819-0244</p>
</div><p>Email: hello@restartlife.co</p>
<div class="lb-trans"><p>电子邮件：hello@restartlife.co</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8801/286069_1dd4f052a431db07_logo.jpg" alt="" original-src="https://images.newsfilecorp.com/files/8801/286069_1dd4f052a431db07_logo.jpg"/></p>
<p>To view the source version of this press release, please visit https://www.newsfilecorp.com/release/286069</p>
<div class="lb-trans"><p>要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/286069</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/286069/375" alt="" original-src="https://api.newsfilecorp.com/newsinfo/286069/375"/></p>

Restart Life 宣布与曼尼托巴大学食品技术与研究中心展开合作 | NMLSF 股票新闻